Page last updated: 2024-08-25

5-hydroxymethylcytosine and Parkinson Disease

5-hydroxymethylcytosine has been researched along with Parkinson Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, JL; Chen, TJ; Chen, YJ; Feng, Y; Li, Q; Li, X; Liu, T; Liu, Y; Wu, TT; Wu, YC; Zhu, XY1
Kaut, O; Kuchelmeister, K; Moehl, C; Wüllner, U1
Lei, X; Lv, Q; Yin, X; Zhang, B; Zheng, T1

Other Studies

3 other study(ies) available for 5-hydroxymethylcytosine and Parkinson Disease

ArticleYear
TET2-mediated Cdkn2A DNA hydroxymethylation in midbrain dopaminergic neuron injury of Parkinson's disease.
    Human molecular genetics, 2020, 05-28, Volume: 29, Issue:8

    Topics: 5-Methylcytosine; Animals; Cyclin-Dependent Kinase Inhibitor p16; Dioxygenases; Disease Models, Animal; DNA Methylation; DNA-Binding Proteins; Dopaminergic Neurons; Epigenesis, Genetic; Humans; Male; Mesencephalon; Mice; Parkinson Disease; Proto-Oncogene Proteins

2020
5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease.
    Journal of chemical neuroanatomy, 2019, Volume: 96

    Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Brain; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease

2019
Spatial distribution of 5-hydroxymethyl cytosine in rat brain and temporal distribution in striatum.
    Neurochemical research, 2015, Volume: 40, Issue:4

    Topics: 5-Methylcytosine; Animals; Brain; Corpus Striatum; Cytosine; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley

2015